Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

Nanostructured Active Therapeutics Proposal Deadline Extended

by Global Biodefense Staff
December 31, 2012

The Defense Threat Reduction Agency (DTRA) Chemical and Biological Defense Program (CBDP) has extended the proposal receipt deadline for the Nanostructured Active Therapeutic Vehicles (NATV) initiative. 

The NATV program seeks to advance nanostructured therapeutic materials designed for prophylactic or pre-symptomatic chemical and biological medical countermeasures. Two target-centric thrust areas are emphasized for novel advances: 

Thrust 1: Small-molecule antibiotics, such as those used against Gram-negative bacterial pathogens, particularly Burkholderia mallei and Francisella tularensis. A particular challenge in this thrust is demonstration of targeting infected cells and transport of the therapeutic into the bacterium. 

Thrust 2: Large-molecule bioscavenger Butyrylcholinesterase (BuChE) to deliver broad-spectrum protection against all classes of nerve agents. 

The new submission date for proposals is January 25, 2013. Selections are expected to be announced on February 28, 2013. 

Tags: BAABioscavengersBurkholderiaDefense Threat Reduction AgencyF. tularensisNanotech

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC